Try a new search

Format these results:

Searched for:

person:kyriac01

in-biosketch:true

Total Results:

3


Point To Area of Pain: A Clinically Useful Telehealth Physical Exam Technique for Focal Nociceptive and Neuropathic Pain

Yih, Christopher; Chokshi, Krupali; Kyriakides, Christopher; Seko, Kyle; Wahezi, Sayed; Shaparin, Naum; Vydyanathan, Amaresh; Gallardo, Jean Carlo; Morrow, Lisa; Sperber, Kevin; Hascalovici, Jacob R
BACKGROUND:Chronic pain is a leading cause of disease burden and disability globally. The COVID-19 pandemic catalyzed a major paradigm shift in health care delivery with the universal adoption of telemedicine. Telehealth physical examination is particularly challenging and little guidance is available on this topic. OBJECTIVES:We attempt to describe the Point To the Area of Pain (PTAP) test and establish a consensus regarding its utility for musculoskeletal examination (MSK) via telehealth. STUDY DESIGN:The authors drafted an online survey. SETTING:The survey was sent to physicians and nurse practitioners within the authors' respective departments and institutions who routinely use telemedicine to treat pain METHODS: Respondents (n = 61) were asked about their primary specialty, comfort level in evaluating patients in pain, use of the PTAP test and its perceived clinical relevance to patient management, and other relevant questions. RESULTS:Respondents were predominantly trained in Physiatry (47.5%), Anesthesiology (23%), Neurology (13.1%) and Family Medicine (11.5%); 67.2% of providers treat pain related diseases > 75% of the time; 50.8% of respondents were "somewhat comfortable" at performing a virtual MSK exam and 29.5% were "not comfortable"; 65.5% utilize the PTAP test and 88.5% agree or strongly agree that this test provides extrinsic clinically relevant information. LIMITATIONS:The relatively small number of respondents. CONCLUSION:PTAP tests should not replace the standard accepted in-person or virtual physical examination in practice, but in the absence of a hands-on exam, the PTAP test is a clear and concise test that can easily be performed in conjunction with other techniques via telehealth, and in the context of assessing pain provides useful clinical information that can help guide medical decision making.
PMID: 35322979
ISSN: 2150-1149
CID: 5200572

Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression

Rendeiro, André F; Casano, Joseph; Vorkas, Charles Kyriakos; Singh, Harjot; Morales, Ayana; DeSimone, Robert A; Ellsworth, Grant B; Soave, Rosemary; Kapadia, Shashi N; Saito, Kohta; Brown, Christopher D; Hsu, JingMei; Kyriakides, Christopher; Chiu, Steven; Cappelli, Luca Vincenzo; Cacciapuoti, Maria Teresa; Tam, Wayne; Galluzzi, Lorenzo; Simonson, Paul D; Elemento, Olivier; Salvatore, Mirella; Inghirami, Giorgio
With a rising incidence of COVID-19-associated morbidity and mortality worldwide, it is critical to elucidate the innate and adaptive immune responses that drive disease severity. We performed longitudinal immune profiling of peripheral blood mononuclear cells from 45 patients and healthy donors. We observed a dynamic immune landscape of innate and adaptive immune cells in disease progression and absolute changes of lymphocyte and myeloid cells in severe versus mild cases or healthy controls. Intubation and death were coupled with selected natural killer cell KIR receptor usage and IgM+ B cells and associated with profound CD4 and CD8 T-cell exhaustion. Pseudo-temporal reconstruction of the hierarchy of disease progression revealed dynamic time changes in the global population recapitulating individual patients and the development of an eight-marker classifier of disease severity. Estimating the effect of clinical progression on the immune response and early assessment of disease progression risks may allow implementation of tailored therapies.
PMCID:7768198
PMID: 33361110
ISSN: 2575-1077
CID: 4770952

Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression

Rendeiro, Andre F; Casano, Joseph; Vorkas, Charles Kyriakos; Singh, Harjot; Morales, Ayana; DeSimone, Robert A; Ellsworth, Grant B; Soave, Rosemary; Kapadia, Shashi N; Saito, Kohta; Brown, Christopher D; Hsu, JingMei; Kyriakides, Christopher; Chui, Steven; Cappelli, Luca; Cacciapuoti, Maria Teresa; Tam, Wayne; Galluzzi, Lorenzo; Simonson, Paul D; Elemento, Olivier; Salvatore, Mirella; Inghirami, Giorgio
With a rising incidence of COVID-19-associated morbidity and mortality worldwide, it is critical to elucidate the innate and adaptive immune responses that drive disease severity. We performed longitudinal immune profiling of peripheral blood mononuclear cells from 45 patients and healthy donors. We observed a dynamic immune landscape of innate and adaptive immune cells in disease progression and absolute changes of lymphocyte and myeloid cells in severe versus mild cases or healthy controls. Intubation and death were coupled with selected natural killer cell KIR receptor usage and IgM+ B cells and associated with profound CD4 and CD8 T cell exhaustion. Pseudo-temporal reconstruction of the hierarchy of disease progression revealed dynamic time changes in the global population recapitulating individual patients and the development of an eight-marker classifier of disease severity. Estimating the effect of clinical progression on the immune response and early assessment of disease progression risks may allow implementation of tailored therapies.
PMCID:7491529
PMID: 32935114
ISSN: n/a
CID: 4627472